KLYG (Kelyniam Global) Stock Based Compensation: $0.00 Mil (TTM As of Mar. 2008)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kelyniam Global Stock Based Compensation?

Kelyniam Global KLYG -9.66% Stock Based Compensation is $0.00 Mil as of Mar. 2008.

Kelyniam Global's Stock Based Compensation for the three months ended in Mar. 2008 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2008 was $0.00 Mil.

Kelyniam Global Stock Based Compensation Related Terms

Kelyniam Global Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Kelyniam Global's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kelyniam Global Stock Based Compensation Chart

Kelyniam Global Annual Data
Trend Dec06 Dec07
Stock Based Compensation
0.00 0.00

Kelyniam Global Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Stock Based Compensation Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Kelyniam Global Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
Kelyniam Global (KLYG) has a Stock Based Compensation of $0.00 Mil as of Mar. 2008. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Kelyniam Global and its competitors.
Is Kelyniam Global's Stock Based Compensation too high?
Kelyniam Global's current Stock Based Compensation is $0.00 Mil.
How does Kelyniam Global's Stock Based Compensation compare to VASO and WCUI?
Kelyniam Global's Stock Based Compensation of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Kelyniam Global and its competitors. Kelyniam Global's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelyniam Global stock overvalued right now?
Kelyniam Global (KLYG) has a current Stock Based Compensation of $0.00 Mil. The current Stock Based Compensation is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Kelyniam Global (KLYG), the current Stock Based Compensation is $0.00 Mil as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kelyniam Global Business Description

Address 97 River Road, Suite A, Canton, CT, USA, 06019
Kelyniam Global Inc specializes in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer aided manufacturing of developed medical grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures. The Company's business operations consist of regulatory approvals, manufacturing operations and distribution to customers and markets in the United States.